鉴定了一种Musashi2转位作为骨髓性白血病中的新瘤基因
Kyle Spinler1,2, Michael Hamilton1,2, Jeevisha Bajaj1,2
1Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.
eLife
|January 7, 2026
概括
MSI2-HOXA9转位在髓性白血病中起到第二次作用,导致激进的爆发性危机CML. 这种致癌的融合增强了线粒体呼吸,这表明MSI2是各种癌症潜在的驱动突变.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 血液学 血液学 血液学
背景情况:
- 骨髓性白血病是一种侵袭性癌症,通常是由瘤转位驱动的.
- 慢性骨髓性白血病 (CML) 通过二次遗传事件发展为耐药性爆发性危机 (bcCML).
- 在癌症,特别是BCCML中MSI2-HOXA9转位的作用以前是未知的.
研究的目的:
- 调查MSI2-HOXA9转位作为第二次成功驾驶bcCML中的作用.
- 阐明MSI2-HOXA9有助于BCCML攻击性的机制.
- 探索MSI2在癌症中的致癌潜力.
主要方法:
- 在体内疾病建模,比较BCR-ABL与BCR-ABL/MSI2-HOXA9.
- 对MSI2-HOXA9进行域映射以确定关键的功能区域.
- 对下游分子变化的分析,包括线粒体基因表达和呼吸.
- 评估MSI2在其他转移中的作用.
主要成果:
- 在体内,BCR-ABL/MSI2-HOXA9诱导的疾病比单独的BCR-ABL更具侵略性,其特点是延迟时间降低和致死率增加.
- MSI2-HOXA9导致了分化阻塞,这是bcCML的一个标志.
- MSI2的RNA结合域RRM1对于bcCML的生长和致命性至关重要.
- MSI2-HOXA9上调了线粒体成分,通过POLRMT增加了细胞呼吸.
- 发现MSI2在各种转移中经常成为合作伙伴.
结论:
- MSI2-HOXA9作为一种致癌的第二次打击,促进BCCML的进展和攻击性.
- MSI2-HOXA9通过增加线粒体功能和呼吸来增强BCCML.
- MSI2是一种致癌的驱动因素,其转位可能导致固体癌症.
关键词:
在MSI2-HOXA9中转移位置.马萨希 (Musashi) 是一个名字.bcCMLML 的时间.癌症生物学 癌症生物学这里是鼠标鼠标鼠标鼠标鼠标鼠标.骨髓性白血病是一种白血病.在基因上,我们发现了基因上的差异.更多相关视频
09:45Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
11.7K
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
8.0K
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Differentiation of Common Myeloid Progenitor Cells
3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
